Harald Fricke
Director Técnico/Científico/I+D en Apogenix AG .
Perfil
Harald Fricke is a professional with a doctorate degree from RWTH Aachen University and Universität zu Lübeck.
He is currently the Chief Medical Officer at Apogenix AG since 2006.
Prior to this, he held positions as Vice President-Global Clinical Development at Neovii Biotech GmbH, and as Principal at GlaxoSmithKline GmbH & Co. KG and SmithKline Beecham Pharma GmbH & Co. KG.
Cargos activos de Harald Fricke
| Empresas | Cargo | Inicio |
|---|---|---|
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Director Técnico/Científico/I+D | 01/01/2006 |
Antiguos cargos conocidos de Harald Fricke.
| Empresas | Cargo | Fin |
|---|---|---|
GlaxoSmithKline GmbH & Co. KG
 GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. | Corporate Officer/Principal | - |
SmithKline Beecham Pharma GmbH & Co. KG
 SmithKline Beecham Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology SmithKline Beecham Pharma GmbH & Co. KG is a manufacturer of pharmaceuticals. The company was founded in 1989 and is headquartered in Munich, Germany, with manufacturing facilities within the country. | Corporate Officer/Principal | - |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Corporate Officer/Principal | - |
Formación de Harald Fricke.
| RWTH Aachen University | Doctorate Degree |
| Universität zu Lübeck | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Apogenix AG
Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Health Technology |
Neovii Biotech GmbH
Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Health Technology |
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline GmbH & Co. KG is a German pharmaceutical company. The company is based in Munich, Germany. The CEOs of the company are Jean-Bernard Siméon, Adrian Bauer. | Health Technology |
SmithKline Beecham Pharma GmbH & Co. KG
SmithKline Beecham Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology SmithKline Beecham Pharma GmbH & Co. KG is a manufacturer of pharmaceuticals. The company was founded in 1989 and is headquartered in Munich, Germany, with manufacturing facilities within the country. | Health Technology |
- Bolsa de valores
- Insiders
- Harald Fricke
